Anti-A and anti-B haemagglutinin levels in intravenous immunoglobulins: Are they on the rise? A comparison of four different analysis methods and six products

Biologicals

Volumn 42, Issue 1, 2014, Pages 57-64

  Bellac, C L ^a   Polatti, D ^a   Hottiger, T ^a   Girard, P ^a   Sanger M ^a   Gilgen, M ^a  

^a Swissmedic   (Switzerland)

Author keywords

Anti A haemagglutinin; Anti B haemagglutinin; Haemolysis; Intravenous immunoglobulins; IVIG

Indexed keywords

HEMAGGLUTININ; IMMUNOGLOBULIN;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HEMAGGLUTINATION TEST; INTERMETHOD COMPARISON; MEASUREMENT ACCURACY; PRIORITY JOURNAL; RELIABILITY;

ANTI-A HAEMAGGLUTININ; ANTI-B HAEMAGGLUTININ; BOVINE SERUM ALBUMIN; BSA; EUROPEAN PHARMACOPOEIA; HAEMOLYSIS; IGG; IMMUNOGLOBULIN G; INTRAVENOUS IMMUNOGLOBULIN; INTRAVENOUS IMMUNOGLOBULINS; IVIG; NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL; NIBSC; PBS; PH. EUR.; PHOSPHATE BUFFERED SALINE; RBC; RED BLOOD CELLS; RHESUS D-NEGATIVE, PHENOTYPE CCDDEE; RR;

HEMAGGLUTININS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; REPRODUCIBILITY OF RESULTS;

EID: 84891738724     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2013.10.004     Document Type: Article

References (23)

1. Burnouf T. Modern plasma fractionation. Transfus Med Rev 2007, 21:101-117.
2. Nolte M.T., Pirofsky B., Gerritz G.A., Golding B. Intravenous immunoglobulin therapy for antibody deficiency. Clin Exp Immunol 1979, 36:237-243.
3. Imbach P., Barandun S., d'Apuzzo V., Baumgartner C., Hirt A., Morell A., et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981, 1:1228-1231.
4. Gelfand E.W. Intravenous immune globulin in autoimmune and inflammatory diseases. NEngl J Med 2012, 367:2015-2025.
5. Farrugia A., Evers T., Falcou P.F., Burnouf T., Amorim L., Thomas S. Plasma fractionation issues. Biologicals 2009, 37:88-93.
6. Radosevich M., Burnouf T. Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance. Vox Sang 2010, 98:12-28.
7. Funk M., Lohmann A., Keller-Stanislawski B. Erhöhte Melderate von schweren hämolytischen Reaktionen nach der intravenösen Gabe von Immunglobulinen. Bulletin zur Arzneimittelsicherheit 2012, 2:15-17.
8. Kahwaji J., Barker E., Pepkowitz S., Klapper E., Villicana R., Peng A., et al. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients. Clin J Am Soc Nephrol 2009, 4:1993-1997.
9. Daw Z., Padmore R., Neurath D., Cober N., Tokessy M., Desjardins D., et al. Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis. Transfusion 2008, 48:1598-1601.
10. Matejtschuk P., Chidwick K., Prince A., More J.E., Goldblatt D. Adirect comparison of the antigen-specific antibody profiles of intravenous immunoglobulins derived from US and UK donor plasma. Vox Sang 2002, 83:17-22.
11. Anti-A, anti-B haemagglutinins, general chapter 2.6.20. Ph. Eur 2011, Council of Europe, Strasbourg, France. 7th ed.
12. Human normal immunoglobulin for intravenous administration, monograph 0918. Ph. Eur. Suppl.7.5 2012, Council of Europe, Strasbourg, France.
13. Jan K.M., Chien S. Role of surface electric charge in red blood cell interactions. JGen Physiol 1973, 61:638-654.
14. Thorpe S.J., Fox B., Sharp G., Heath A.B., Behr-Gross M.E., Terao E., et al. International collaborative study to evaluate candidate reference reagents to standardize haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulin products. Vox Sang 2009, 97:160-168.
15. Coombs R.R., Mourant A.E., Race R.R. Anew test for the detection of weak and incomplete Rh agglutinins. Br J Exp Pathol 1945, 26:255-266.
16. Bio-Rad NaCl, enzyme test and cold agglutinins 2010, B005014 05.10.
17. Bio-Rad Coombs Anti-IgG direct and indirect antiglobulin test 2011, B004024 07.11.
18. Cherian G., Search S., Thomas E., Poole J., Davies S.V., Massey E. An acute haemolytic transfusion reaction caused by anti-Wr(a). Transfus Med 2007, 17:312-314.
19. Buchanan D.I., Afaganis A. The Bennett-Goodspeed-Sturgeon or "Donna" red cell antigen and antibody. Vox Sang 1963, 8:213-218.
20. Park T.S., Kim K.U., Jeong W.J., Kim H.H., Chang C.L., Chung J.S., et al. Acute hemolytic transfusion reactions due to multiple alloantibodies including anti-E, anti-c and anti-Jkb. JKorean Med Sci 2003, 18:894-896.
21. Thorpe S.J., Fox B.J., Dolman C.D., Thorpe R. Anti-A and anti-B activity in batches of different intravenous immunoglobulin products determined using a direct haemagglutination method. Biologicals 2005, 33:111-116.
22. Dhainaut F., Guillaumat P.O., Dib H., Perret G., Sauger A., de Coupade C., et al. Invitro and invivo properties differ among liquid intravenous immunoglobulin preparations. Vox Sang 2013, 104:115-126.
23. Thorpe S.J., Fox B., Sharp G., Heath A.B., Behr-Gross M.E., Terao E., et al. International collaborative study to establish reference preparations to standardise haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulins by the direct method. Pharmeur Bio Sci Notes 2010, 2010:39-50.